BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
19.14
+0.70 (3.80%)
Nov 22, 2024, 4:00 PM EST - Market closed
BioAge Labs Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -70.94 | -63.85 | -39.72 |
| Depreciation & Amortization | 0.16 | 0.16 | 0.13 |
| Stock-Based Compensation | 5.03 | 3.02 | 2.54 |
| Other Operating Activities | 8.74 | 16.6 | 0.08 |
| Change in Accounts Payable | 1.44 | -0.39 | 0.99 |
| Change in Unearned Revenue | -3.31 | 3.31 | - |
| Change in Other Net Operating Assets | 3.99 | 3.79 | -0.2 |
| Operating Cash Flow | -54.89 | -37.36 | -36.18 |
| Capital Expenditures | -0.34 | -0.17 | -0.1 |
| Investment in Securities | - | -0.1 | - |
| Investing Cash Flow | -0.34 | -0.27 | -0.1 |
| Short-Term Debt Issued | - | 23.5 | - |
| Long-Term Debt Issued | - | 12.5 | 2.5 |
| Total Debt Issued | - | 36 | 2.5 |
| Long-Term Debt Repaid | - | -1 | - |
| Net Debt Issued (Repaid) | -5.5 | 35 | 2.5 |
| Issuance of Common Stock | 194.61 | 0 | 0.04 |
| Other Financing Activities | -3.82 | -0.06 | -0.05 |
| Financing Cash Flow | 355.29 | 34.94 | 2.5 |
| Foreign Exchange Rate Adjustments | -0.12 | - | 0.25 |
| Net Cash Flow | 299.94 | -2.69 | -33.54 |
| Free Cash Flow | -55.23 | -37.53 | -36.28 |
| Free Cash Flow Per Share | -25.79 | -22.43 | -21.70 |
| Cash Interest Paid | 1.61 | 1.16 | 0.13 |
| Levered Free Cash Flow | - | -27.91 | - |
| Unlevered Free Cash Flow | - | -23.04 | - |
| Change in Net Working Capital | - | -4.2 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.